Articles related to PEDIATRIC DERMATOLOGY

Roflumilast cream 0.15% demonstrates rapid and significant improvement in itch within 24 hours of the first application, addressing a primary concern for atopic dermatitis patients.

Pityriasis alba presents unique diagnostic and management challenges, particularly in diverse patient populations. Understanding its clinical course and potential associations with other dermatological conditions is crucial for optimal patient care and education.

A recent case of a 9-year-old boy diagnosed with acrodermatitis enteropathica reinforces the critical role of regular monitoring and dose adjustment of zinc supplementation in pediatric patients, particularly during periods of rapid growth.

This case underscores the importance of considering Mycoplasma pneumoniae in differential diagnoses when patients present with symptoms such as painful lip crusting, oral ulcers, rash, and genital pain. Early diagnosis can lead to timely treatment and favorable prognosis.

Approved for AD in adults a year ago, abrocitinib is now available for individuals over 12 years old with moderate to severe atopic dermatitis that is not adequately controlled with other systemic therapy.